Inventor
Thomas D. Harris
Inventor
Salem, NH, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
C07DHeterocyclic compounds28%
C07KPeptides18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
C07BGeneral methods of organic chemistry6%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
PatentTitleYear
7,332,149'Vitronectin receptor antagonist pharmaceuticals'20087,321,045'Vitronectin receptor antagonist pharmaceuticals'20087,052,673'Pharmaceuticals for the imaging of angiogenic disorders'20067,018,611'Vitronectin receptor antagonist pharmaceuticals'20066,800,273'Pharmaceuticals for the imaging of angiogenic disorders'20046,794,518'Vitronectin receptor antagonist pharmaceuticals'20046,743,412'Vitronectin receptor antagonist pharmaceuticals'20046,689,337'Vitronectin receptor antagonist pharmaceuticals'20046,683,163'Vitronectin receptor antagonist pharmaceuticals'20046,537,520'Pharmaceuticals for the imaging of angiogenic disorders'20036,524,553'Quinolone vitronectin receptor antagonist pharmaceuticals'20036,511,649'Vitronectin receptor antagonist pharmaceuticals'20036,511,648'Vitronectin receptor antagonist pharmaceuticals'20036,416,733'Radiopharmaceuticals for imaging infection and inflammation'20026,322,770'Indazole vitronectin receptor antagonist pharmaceuticals'20016,022,523'Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders'20006,015,904'Stable reagents for the preparation of radio pharmaceuticals'20005,879,657'Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders'19995,750,088'Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals'19985,688,485'Radiolabelled complexes of ester-substituted diaminethiols'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–1999Patents assigned to DU PONT MERCK PHARMA (3)· patent assignee history
1997–2008Based in Salem, NH, US· patent location history
2000–2001Patents assigned to DU PONT PHARM CO (2)· patent assignee history
2002–2008Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (13)· patent assignee history
2003–2006Based in Samel, NH, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB PHARMA CO | 13 | 2002–2008 |
| DU PONT MERCK PHARMA | 3 | 1997–1999 |
| DU PONT PHARM CO | 2 | 2000–2001 |
Locations
| Location | Patents | Span |
|---|---|---|
| Salem, NH, US | 17 | 1997–2008 |
| Samel, NH, US | 3 | 2003–2006 |